Adprotech Limited
Records under this name other than patents Adprotech Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,455,447 | Modified therapeutic agents Term ended Term ended Apr 26, 2024 · From the USPTO record | Term ended | Term ended Apr 26, 2024 | From the USPTO record |
| US 7,078,380 | Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane associating elements Formerly held Term ended Term ended Nov 2, 2021 · From the USPTO record | Term ended | Term ended Nov 2, 2021 | From the USPTO record |
| US 7,655,617 | Conjugates of soluble peptidic compounds with membrane-binding agents Lapsed on the fee record Ended Feb 2, 2018 · From the USPTO record | Lapsed on the fee record | Ended Feb 2, 2018 | From the USPTO record |
| US 6,713,606 | Conjugates of soluble peptidic compounds with membrane-binding agents Lapsed on the fee record Ended Mar 30, 2016 · From the USPTO record | Lapsed on the fee record | Ended Mar 30, 2016 | From the USPTO record |
| US 7,888,318 | Method of preparing an organ by perfusion Lapsed on the fee record Ended Feb 15, 2015 · From the USPTO record | Lapsed on the fee record | Ended Feb 15, 2015 | From the USPTO record |
| US 6,797,806 | Fragments of CR1 and their use Lapsed on the fee record Ended Sep 28, 2012 · From the USPTO record | Lapsed on the fee record | Ended Sep 28, 2012 | From the USPTO record |
| US 6,770,631 | Non-identical genes and their application in improved molecular adjuvants Lapsed on the fee record Ended Aug 3, 2012 · From the USPTO record | Lapsed on the fee record | Ended Aug 3, 2012 | From the USPTO record |
| US 6,833,437 | Complement receptor type 1 (CR1)-like sequences Lapsed on the fee record Ended Dec 21, 2008 · From the USPTO record | Lapsed on the fee record | Ended Dec 21, 2008 | From the USPTO record |
| US 5,302,390 | Hybrid proteins of human plasminogen and human t-PA, pharmaceutical compositions and methods of treatment Formerly held Term ended Term ended no later than Apr 12, 2014 · Low confidence | Term ended | Term ended no later than Apr 12, 2014 | Low confidence |
| US 5,833,989 | Soluble CR1 derivatives Term ended Term ended no later than Nov 10, 2018 · Low confidence | Term ended | Term ended no later than Nov 10, 2018 | Low confidence |